LAKEWOOD, NJ — October 01, 2012 — As one of the first eSampling providers in the industry, and a leader in Pharma dedicated technology solutions, J. Knipper and Company Inc. announced today that its flagship Software as a Service (SaaS) product, MySampleCloset.com®, has gone “mobile”. In keeping with the growing prescriber preference for iPad based tools and online access to resources, Knipper has just released MySampleCloset.com® MOBILE for the iPhone and iPad.
MySampleCloset.com® MOBILE continues Knipper’s tradition of providing simple and secure online sample access to prescribers across the country. In addition, the new mobile app introduces Knipper’s highly innovative new “Paperless AOC Processing” technology which integrates cloud based AOC (Acknowledgement of Content) data and the simplicity of QR code scanning allowing prescribers to close their AOC instantly and effortlessly upon receipt of their order. Steve Gransden, Vice President of Marketing at J. Knipper and Company, Inc., commented “Since the release of the new mobile app, our new Paperless AOC Process has virtually taken on a life of its own. Many of our Pharmaceutical customers have already asked to have this process integrated into other solutions across their white space and sales force initiatives”.
As Knipper released the new MySampleCloset.com® MOBILE application as a free download through the Apple app store, it was reported that additional mobile projects had already been launched across its Software as a Service suite of direct to prescriber and sales force support products. Mr. Gransden also stated that “as the digital market continues to evolve the landscape of sample related activities, Knipper will continue to blaze a path of mobile innovation across its many core business services”. Next in line for mobile release will be Knipper’s highly touted MyRepCenter.com® online ordering system for the Pharmaceutical SalesForce. The mobile release of this highly seasoned 5 th generation SaaS platform is anticipated for beta release later this year. With full commercial release anticipated for Q1 of 2013.